The effect of intra-ovarian androgen priming on ovarian reserve parameters in Bologna poor responders.

[1]  P. Humaidan,et al.  Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders , 2017, Human reproduction.

[2]  S. Esteves,et al.  The novel POSEIDON stratification of ‘Low prognosis patients in Assisted Reproductive Technology’ and its proposed marker of successful outcome , 2016, F1000Research.

[3]  C. Venetis,et al.  Transdermal testosterone pretreatment in poor responders undergoing ICSI: a randomized clinical trial. , 2016, Human reproduction.

[4]  S. Bhattacharya,et al.  Trends in 'poor responder' research: lessons learned from RCTs in assisted conception. , 2016, Human reproduction update.

[5]  A. Loft,et al.  Endocrine effects of hCG supplementation to recombinant FSH throughout controlled ovarian stimulation for IVF: a dose–response study , 2013, Clinical endocrinology.

[6]  L. Gianaroli,et al.  ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. , 2011, Human reproduction.

[7]  K. Møllgård,et al.  In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA. , 2011, Molecular human reproduction.

[8]  J. Balasch,et al.  Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial. , 2009, Human reproduction.

[9]  A. Loft,et al.  Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial. , 2008, Human reproduction.

[10]  J. Wolf,et al.  Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique--a prospective, randomized, double-blind study. , 2006, Human reproduction.

[11]  A. Loft,et al.  Androgen priming using aromatase inhibitor and hCG during early-follicular-phase GnRH antagonist down-regulation in modified antagonist protocols. , 2006, Human reproduction.

[12]  C. Bondy,et al.  Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. , 1999, The Journal of clinical endocrinology and metabolism.

[13]  C. Bondy,et al.  Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary. , 1999, Biology of reproduction.

[14]  C. Bondy,et al.  Androgens stimulate early stages of follicular growth in the primate ovary. , 1998, The Journal of clinical investigation.

[15]  R. Nahum,et al.  Metabolic regulation of androgen production by human thecal cells in vitro. , 1995, Human reproduction.

[16]  A. Mason,et al.  Effect of recombinant inhibin on androgen synthesis in cultured human thecal cells , 1991, Molecular and Cellular Endocrinology.

[17]  J. G. van den Tweel,et al.  The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects. , 1989, The Journal of clinical endocrinology and metabolism.